Does GOSERELIN Cause Breast cancer metastatic? 149 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Breast cancer metastatic have been filed in association with GOSERELIN (ZOLADEX). This represents 2.3% of all adverse event reports for GOSERELIN.
149
Reports of Breast cancer metastatic with GOSERELIN
2.3%
of all GOSERELIN reports
13
Deaths
25
Hospitalizations
How Dangerous Is Breast cancer metastatic From GOSERELIN?
Of the 149 reports, 13 (8.7%) resulted in death, 25 (16.8%) required hospitalization.
Is Breast cancer metastatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOSERELIN. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does GOSERELIN Cause?
Death (1,293)
Malignant neoplasm progression (935)
Metastases to bone (397)
Neutropenia (339)
Fatigue (309)
Off label use (272)
Metastases to liver (264)
Hot flush (263)
Asthenia (213)
Arthralgia (190)
What Other Drugs Cause Breast cancer metastatic?
LETROZOLE (1,540)
RIBOCICLIB (1,450)
FULVESTRANT (1,165)
PALBOCICLIB (818)
TRASTUZUMAB (720)
CAPECITABINE (718)
PACLITAXEL (651)
EVEROLIMUS (634)
EXEMESTANE (591)
TAMOXIFEN (515)
Which GOSERELIN Alternatives Have Lower Breast cancer metastatic Risk?
GOSERELIN vs GRAMICIDIN
GOSERELIN vs GRAMICIDIN\NEOMYCIN\POLYMYXIN B
GOSERELIN vs GRAMICIDIN\POLYMYXIN B
GOSERELIN vs GRANISETRON
GOSERELIN vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS